A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
AC131097.4 | Protein LOC285095 | | | | | | Tissue enhanced |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACMSD | Aminocarboxymuconate semialdehyde decarboxylase | Enzymes
| | | | | Group enriched |
ACOT12 | Acyl-CoA thioesterase 12 | Enzymes Transporters
| | | | | Tissue enriched |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes
| | | | | Tissue enhanced |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACRV1 | Acrosomal vesicle protein 1 | Predicted secreted proteins
| | | | | Tissue enriched |
ACSBG2 | Acyl-CoA synthetase bubblegum family member 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
ACTA1 | Actin, alpha 1, skeletal muscle | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
ACTC1 | Actin, alpha, cardiac muscle 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |
ACTL7A | Actin-like 7A | Cytoskeleton related proteins
| | | | | Tissue enriched |
ACTL7B | Actin-like 7B | | | | | | Tissue enriched |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
ADGB | Androglobin | Enzymes
| | | | | Group enriched |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |